Purchase Order 75D30119P04084

Award Date 5/17/19
Potential Completion Date 5/30/20
Potential Value $150K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services, to Ai Biosciences, Inc., a small disadvantaged business, through the Small Business Innovation Research (SBIR) program. The contract is for the development of a point-of-care diagnostic test to detect gonorrhea and determine antimicrobial susceptibility. The potential value of the contract is $299,652.00, and the period of performance runs from August 8,...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $70,000 purchase order to Hologic Sales And Service, LLC for assay kits. Hologic Sales And Service, LLC is a division of Hologic, Inc., which will serve as the prime contractor. Performance will take place in Atlanta, Georgia over a three week period concluding on August 1, 2023. This firm fixed price contract supports the CDC's efforts to monitor and test for diseases through the...
This is a $5,940,307.00 definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Southern California (USC) for the development of a self-test device for gonorrhea. The contract has no set-aside designation. As the prime contractor, USC will oversee the project, which involves subcontractors Diagnostic Consulting Network, LLC and Foundation For Innovative New Diagnostics (FIND), a foreign non-profit organization, to develop rapid lateral...
This is a firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Hologic, Inc. for research and development (R&D) services. The contract has a ceiling value of $2,441,030.81 and a period of performance through September 29, 2025. The contract was awarded on September 30, 2024 without a set-aside designation. Hologic, Inc. is a medical technology company that provides a range of products and services to federal government agencies,...
This is a $1,949,922.00 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Hologic Sales And Service, LLC, a medical technology company based in Marlborough, Massachusetts. The contract is for the delivery of Aptima Combo 2 CT/GC 250 test kits, which are used for the detection of chlamydia and gonorrhea infections. The award has an ultimate completion date of September 30, 2027. The original solicitation was a Special Notice issued by the Regional Health Contracting...
The federal contract award is for a HOLOGIC SERVICE AGREEMENT with a ceiling value of $94,500.00. The prime contractor is Hologic Sales And Service, LLC, a division of the parent company Hologic, Inc. The contract is for maintenance and repair services for Hologic medical equipment, including HIV-1 viral load testing platforms, used by the Centers for Disease Control and Prevention (CDC). The contract was awarded on a sole-source basis, as Hologic is the only vendor capable of providing the...
Hologic, Inc. was awarded a $131,397.51 firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh for the PANTHER SYSTEM PRODUCT NO. 303095. As the original equipment manufacturer and sole source provider, Hologic will deliver its proprietary Panther molecular diagnostics platform and associated reagents to enable rapid infection testing. No set-aside provision was used for this award made to Hologic's Marlborough, MA...
Hologic, Inc. was awarded a $10.986 million firm fixed price purchase order by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to provide APTIMA SARS-COV-2 tests on Hologic Panther systems. The tests and associated diagnostic equipment will support the federal government's response efforts to the Coronavirus COVID-19 pandemic and will be delivered to a location in San Diego, California over a one year period concluding in August...
This federal contract award is for CHLAMYDIA TRACHOMATIS AND NEISSERIA GONO testing services, with a ceiling value of $612,500.00. The award was made to Gen-Probe Incorporated, a medical diagnostics company specializing in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The award is not designated as a set-aside contract. Gen-Probe Incorporated is a subsidiary of the parent company Hologic, Inc., which is a major supplier of...
This is a $4,960,081.66 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The contract is for a clinical study of a single-use, point-of-care molecular diagnostic device for the detection of sexually transmitted infections including Neisseria gonorrhoeae, Trichomonas vaginalis, and Chlamydia trachomatis using vaginally...

This federal contract award to Hologic, Inc. is for the development of a diagnostic test to detect antimicrobial resistance in the bacterium Neisseria gonorrhoeae (NG). The $149,900 firm fixed-price purchase order was awarded on May 17, 2019 by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract has a completion date of May 30, 2020 and does not utilize any set-aside designations. Hologic, Inc. is the prime contractor for this award, which is associated with the company's medical technology and diagnostics capabilities, particularly its expertise in women's health and infectious disease testing. The CDC, as the funding agency, is likely procuring this diagnostic test to enhance its efforts to monitor and address the growing threat of antimicrobial resistance in sexually transmitted infections.

Generated 3/22/24, 10:49 PM